Reported in The Week, 17 July 2021:
Taking aspirin alongside conventional treatments may reduce the risk of cancer patients dying by 20%, a new analysis has found. The researchers, at Cardiff University, also found that the painkiller appeared to reduce the risk of the cancer spreading within the body.
Their review covered 118 earlier studies, involving patients with 18 different cancers. The 250,000 patients who’d reported taking aspirin (as a supplement to other treatments) had a 20% reduced mortality rate.
“There is now a considerable body of evidence to suggest a significant reduction in mortality in patients who take aspirin, said lead author Professor Peter Elwood.